Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Roussel Uclaf transfers all rights and responsibilities related to mifepristone to Dr. Sakiz

April 10, 1997

GelTex issued U.S. patent for cholesterol-reducing polymers

April 10, 1997

Ergoset enters clinical trials as adjunct therapy for type II diabetes

April 10, 1997

Lilly describes agents for postmenopausal syndrome

April 9, 1997

Chronic MK-677 increases GH and IGF-I in dogs

April 8, 1997

Cobalt porphyrins for obesity from Warner-Lambert

April 8, 1997

NO-1886 increases HDL cholesterol by increasing LPL activity

April 7, 1997

Nonoxynol-9 not effective for reducing HIV transmission

April 7, 1997

PPL Therapeutics produces salmon calcitonin in transgenic rabbits

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.